2.1
Linzagolix (Yselty, Theramex) is indicated for the 'treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age'.
Closed for comments This consultation ended on at Request commenting lead permission
Linzagolix (Yselty, Theramex) is indicated for the 'treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age'.
The dosage schedule is available in the summary of product characteristics for linzagolix.
The company has a commercial arrangement This makes linzagolix available to the NHS with a discount. The size of the discount is commercial in confidence. It is the company's responsibility to let relevant NHS organisations know details of this discount.
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions
Question on Consultation
Question on Consultation
Question on Consultation
Question on Consultation